CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 700-878 JSONTXT

{"project":"CORD-PICO","denotations":[{"id":"p1_all4","span":{"begin":0,"end":76},"obj":"Intervention"},{"id":"p1_all5","span":{"begin":109,"end":118},"obj":"Outcome"},{"id":"p1_all6","span":{"begin":122,"end":155},"obj":"Population"},{"id":"p1_all7","span":{"begin":168,"end":178},"obj":"Intervention"},{"id":"p2_i6","span":{"begin":168,"end":177},"obj":"Pharmacological"},{"id":"p2_o2","span":{"begin":109,"end":118},"obj":"Mortality"}],"text":"Entresto®, a combinational angiotensin-receptor blocker/neprilysin inhibitor, showed superiority in reducing mortality in human patients with heart failure compared to enalapril."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":178},"obj":"Sentence"},{"id":"T44569","span":{"begin":0,"end":178},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Entresto®, a combinational angiotensin-receptor blocker/neprilysin inhibitor, showed superiority in reducing mortality in human patients with heart failure compared to enalapril."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T4","span":{"begin":142,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"Entresto®, a combinational angiotensin-receptor blocker/neprilysin inhibitor, showed superiority in reducing mortality in human patients with heart failure compared to enalapril."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5","span":{"begin":142,"end":155},"obj":"Disease"},{"id":"T43405","span":{"begin":142,"end":155},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"},{"id":"A20572","pred":"mondo_id","subj":"T43405","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"}],"text":"Entresto®, a combinational angiotensin-receptor blocker/neprilysin inhibitor, showed superiority in reducing mortality in human patients with heart failure compared to enalapril."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T2","span":{"begin":142,"end":155},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0001635"}],"text":"Entresto®, a combinational angiotensin-receptor blocker/neprilysin inhibitor, showed superiority in reducing mortality in human patients with heart failure compared to enalapril."}